Fosmidomycin
From Wikipedia, the free encyclopedia
 |
|
|
Fosmidomycin
|
|
| Systematic (IUPAC) name | |
| 3-[Formyl(hydroxy)amino]propoylphosphonic acid | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C4H10NO5P |
| Mol. mass | 183.100 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Fosmidomycin is an antibiotic that specific inhibits DXP reductoisomerase, a key enzyme in the non-mevalonate pathway. It is a structural analogue of 2-C-methyl-D-erythrose 4-phosphate. It inhibits the E. coli enzyme with a KI value of 38 nM (4).
[edit] See also
 |
This antibiotic-related article is a stub. You can help Wikipedia by expanding it. |
